Skip to content
Search

Latest Stories

August 2021 price concessions announced

The Department of Health and Social Care (DHSC) has granted the following price concessions for August 2021:

DrugPack sizePrice Concession
Etoricoxib 90mg tablets28£7.29
Ivabradine 5mg tablets56£12.19
Ivabradine 7.5mg tablets56£12.73
Lercanidipine 10mg tablets28£4.40
Nitrofurantoin 50mg capsules30£11.25
Olmesartan medoxomil 40mg tablets28£9.95
Perindopril erbumine 8mg tablets30£2.40
Pioglitazone 30mg tablets28£2.00
Sulfasalazine 500mg gastro-resistant tablets112£17.19
Sodium fluoride 0.05% mouthwash sugar free250ml£1.72
Sulpiride 200mg tablets30£5.85

DHSC previously announced (17.08.21) the following list of price concessions:


DrugPack sizePrice Concession
Baclofen 10mg tablets84£2.60
Eplerenone 25mg tablets28£10.20
Eplerenone 50mg tablets28£13.80
Etoricoxib 60mg tablets28£7.10
Glyceryl trinitrate 400micrograms/dose pump sublingual spray180£2.89
Glyceryl trinitrate 400micrograms/dose pump sublingual spray200£3.24
Lercanidipine 20mg tablets28£4.49
Loratadine 5mg/5ml oral solution100£6.99
Mebeverine 135mg tablets100£4.25
Naftidrofuryl 100mg capsules84£7.39
Pregabalin 100mg capsules84£5.25
Pregabalin 300mg capsules56£5.39
Pregabalin 50mg capsules84£4.60
Pregabalin 75mg capsules56£3.76
Prochlorperazine 5mg tablets28£1.69
Tolbutamide 500mg tablets28£16.79
Trazodone 100mg capsules56£3.65
Trimethoprim 200mg tablets6£1.24
Trimethoprim 200mg tablets14£2.90
Trimethoprim 50mg/5ml oral suspension sugar free100£11.52
Ursodeoxycholic acid 250mg capsules60£11.59

Further information on price concessions and FAQs about the process involved can be found here, on the website of the Pharmaceutical Services Negotiating Committee (PSNC).

A price concession only applies for the month in which it is granted. No additional prescription endorsement are required as the new price is automatically applied by the NHSBSA to all items submitted for payment in the same month for which a price concession is granted.

PSNC says it is still working with the DHSC to agree further concessionary prices on other drugs reported to be unavailable at the stated August 2021 Drug Tariff price.

More For You

GPhC should consider reduced fees for pharmacists non-practising practising, says RPS

RPS responds to GPhC consultation on draft changes to fees

gettyimages

RPS urges GPhC to reduce registration fees for non-practising pharmacists

The Royal Pharmaceutical Society (RPS) has called on the General Pharmaceutical Council (GPhC) to reduce annual registration fees for non-practising pharmacists — such as those on parental leave or with a long-term illness — in response to the regulator’s consultation on proposed changes to fees.

The GPhC is proposing a 6% increase in annual registration fees from September 2025 to cover the rising operational costs.

Keep ReadingShow less
Hay fever treatment: Dymista nasal spray now available in pharmacies without prescription

Hay fever affects one in four people in the UK

gettyimages

Hay fever treatment: First OTC combination nasal spray launched

For the first time, a double-action combination treatment for moderate to severe hay fever has been available over the counter across UK pharmacies, offering a new option for those sufferers who remain uncontrolled on a corticosteroid or antihistamine nasal spray.

Launched by global healthcare company Viatris, Dymista® CONTROL (azelastine hydrochloride and fluticasone propionate) nasal spray— previously only available via prescription under the brand name Dymista — can be accessed without a GP visit.

Keep ReadingShow less
Nick Kaye
Nick Kaye appointed as NPA's new chair
Nick Kaye appointed as NPA's new chair

Breaking news: NPA members advised against collective action

With the government’s recent announcement of increased funding to the sector signalling a ‘clear step forward’, the National Pharmacy Association (NPA) has today announced that it will not be recommending collective action to its members.

Last month, the department of health announced the Community Pharmacy Contractual Framework (CPCF) with an increase in funding for 2024/25 of £106m to £2.7 billion and simultaneously a further increase to £3.1 billion for 25/26.

Keep ReadingShow less
Slamannan Village Pharmacy sold after 31 years

Slamannan Village Pharmacy

Slamannan Village Pharmacy sold after 31 years

A pharmacy in a small village in Scotland that has served its community for 31 years, has been bought by a group that operates 43 pharmacies across Scotland.

Slamannan Village Pharmacy is heavily relied on by locals sourcing their prescriptions from the village’s sole GP surgery.

Keep ReadingShow less
Kinnock highlights employers’ role in making community pharmacy jobs attractive

The new funding uplift our commitment to rebuilding the sector: Kinnock

Kinnock: ‘Employers have a key role in making community pharmacy jobs attractive’

Health minister Stephen Kinnock has emphasised that employers have a crucial role to play in retaining staff and making careers in community pharmacy more attractive.

His comments came in response to a written question from Victoria Collins MP, the Liberal Democrat spokesperson for science and technology, who asked what steps the Department of Health and Social Care is taking to address staff shortages and prevent the closure of local pharmacies.

Keep ReadingShow less